This week, we’re again focusing on research presented at the International Association for the Study of Lung Cancer 2020 World Conference on Lung Cancer Singapore, which was moved to a virtual format and held January 28 to 31, 2021, in light of the COVID-19 pandemic. We’ll hear about findings in mesothelioma, small cell lung cancer, and drug development. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This...

This week, we’ll discuss the findings of a study that examined the prevalence of KRAS G12C mutations across different populations. Then, we’ll hear recent news about FDA oncology drug approvals in the month of January. Coverage of stories discussed this week on ascopost.com: Prevalence of KRAS G12C Somatic Mutations by Cancer Type, Race, and Sex FDA Approves Crizotinib for Children and Young Adults With Relapsed or Refractory Systemic ALK-Positive ALCL FDA Approves Fam-Trastuzumab...

This week, we’re back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in IDH1-mutated cholangiocarcinoma, and the POLO trial in BRCA-mutated pancreatic cancer. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we’re back for more coverage of the 2021 Gastrointestinal...

The 2021 Gastrointestinal Cancers Symposium, held in a virtual format this year, is being held this weekend, January 15th to 17th, 2021. We’re discussing findings from the meeting with three study authors. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> The 2021 Gastrointestinal Cancers Symposium, held in a virtual format this year, is being held this weekend, January 15th to 17th, 2021. We’re discussing...

This week, we’ll review a meta-analysis of several trials studying the efficacy of 3 vs 6 months of adjuvant chemotherapy for patients with advanced colon cancer. We’ll also discuss a report on the frequency of osteonecrosis of the jaw among patients with metastatic bone disease treated with zoledronic acid, as well as several risk factors for the development of the condition. Coverage of stories discussed this week on ascopost.com: Final Overall Survival Results of the IDEA Collaboration: 3...

The 2020 ASH Annual Meeting & Exposition, held in a virtual format this year, begins today. We’re featuring three studies on the podcast this week from the meeting. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> The 2020 ASH Annual Meeting & Exposition, held in a virtual format this year, begins today. We’re featuring three studies on the podcast this week from the meeting.

As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials. Coverage of stories discussed this week on ascopost.com: Serial COVID-19...

This week, we're focusing on high-impact research in prostate cancer presented during the virtual 2020 ASTRO Annual Meeting. The studies included a focus on GnRH receptor antagonist therapy; imaging-based guidance for radiotherapy intensification; and methods of radiotherapy boosts. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we're focusing on high-impact research in prostate cancer presented...

This week, we’ll be featuring discussions of two late-breaking abstracts presented during the virtual 2020 American Society for Radiation Oncology, or ASTRO, Annual Meeting. The first focuses on the role of imaging to plan treatment with radiotherapy in patients with prostate cancer. The second discusses strategies to manage the pain of spinal metastases. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This...

This week, we’ll focus on two recent approvals from the U.S. Food and Drug Administration in patients with leukemia and lymphoma, respectively. Coverage of stories discussed this week on ascopost.com: FDA Approves Venetoclax Combination Regimen for Certain Adult Patients With AML FDA Extends the Approval of Pembrolizumab for Patients With Classical Hodgkin Lymphoma To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat=...

This week, we’ll be featuring our last disease-specific roundup from the ESMO Virtual Congress 2020. We’ll hear from three experts on their findings in breast cancer, focusing on results from two IMpassion trials as well as the efficacy of a novel antibody-drug conjugate in triple-negative disease, and a telehealth program for patients receiving chemotherapy. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}">...

This week, we’re hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We’ll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we’re hearing about three...

This weekend, the ESMO Virtual Congress 2020 is underway, and we’re sharing interviews with two authors of high-impact papers on breast cancer and head and neck cancer presented at the event. To listen to more podcasts from ASCO, visit asco.org/podcasts. "}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This weekend, the ESMO Virtual Congress 2020 is underway, and we’re sharing interviews with two authors of high-impact papers on breast cancer and head and neck cancer...

We’ll discuss the efficacy of a triplet combination therapy in BRCA-mutated, HER2-negative advanced breast cancer. Then, we’ll move on to a report that detailed multiorgan immunotherapy-related adverse events in patients treated with atezolizumab. Last, we’ll review the FDA’s approval of the RET-targeted therapy pralsetinib in patients with metastatic RET fusion–positive non–small cell lung cancer. Coverage of stories discussed this week on ascopost.com: Addition of Veliparib to...